1. Home
  2. ASTH vs EVO Comparison

ASTH vs EVO Comparison

Compare ASTH & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTH
  • EVO
  • Stock Information
  • Founded
  • ASTH 1994
  • EVO 1993
  • Country
  • ASTH United States
  • EVO Germany
  • Employees
  • ASTH N/A
  • EVO N/A
  • Industry
  • ASTH Professional Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTH Consumer Discretionary
  • EVO Health Care
  • Exchange
  • ASTH Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ASTH 1.7B
  • EVO 1.4B
  • IPO Year
  • ASTH N/A
  • EVO 2021
  • Fundamental
  • Price
  • ASTH $24.00
  • EVO $3.76
  • Analyst Decision
  • ASTH Strong Buy
  • EVO Buy
  • Analyst Count
  • ASTH 8
  • EVO 2
  • Target Price
  • ASTH $53.29
  • EVO $5.90
  • AVG Volume (30 Days)
  • ASTH 220.5K
  • EVO 159.9K
  • Earning Date
  • ASTH 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • ASTH N/A
  • EVO N/A
  • EPS Growth
  • ASTH N/A
  • EVO N/A
  • EPS
  • ASTH 0.73
  • EVO N/A
  • Revenue
  • ASTH $2,250,574,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • ASTH $34.97
  • EVO $10.08
  • Revenue Next Year
  • ASTH $21.52
  • EVO $10.99
  • P/E Ratio
  • ASTH $32.84
  • EVO N/A
  • Revenue Growth
  • ASTH 54.81
  • EVO 1.50
  • 52 Week Low
  • ASTH $23.12
  • EVO $2.84
  • 52 Week High
  • ASTH $63.20
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ASTH 34.33
  • EVO 41.37
  • Support Level
  • ASTH $24.76
  • EVO $4.06
  • Resistance Level
  • ASTH $26.41
  • EVO $4.44
  • Average True Range (ATR)
  • ASTH 0.93
  • EVO 0.11
  • MACD
  • ASTH 0.07
  • EVO -0.04
  • Stochastic Oscillator
  • ASTH 5.06
  • EVO 0.00

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: